Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: cancer


Newsweek trumpets an ‘aggressive’ new cancer drug, but where’s the data?


Are bacteria useful as cancer ‘weapons,’ or far too early to know? Key context missing from HealthDay story

3 8/10/2018

When n=1, it’s easy to jump to conclusions about a therapy working

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery


Washington Post wisely quantifies severe side effects and deaths from CAR-T cell therapy


TIME’s look at new heart drug overlooks high price and potentially fatal risks


In coverage of anti-inflammatory heart drug from Novartis, Reuters keeps it real


NBC News doesn’t back away from shortcomings of new blood test for early cancer detection


Newsweek presents a mostly balanced account of family’s unconventional cancer journey


Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000